Products mentioned by Terry Simpson
Products Terry Simpson has mentioned or recommended across podcast appearances.
SignalCast may earn a small commission on purchases through these links — at no extra cost to you. As an Amazon Associate we earn from qualifying purchases.
Repatha
Recommendedby Regeneron
“Repatha (evolocumab) remains the strongest choice for LDL and ApoB reduction because it carries hard cardiovascular outcomes data showing fewer heart attacks and strokes.”
Praluent
Recommendedby Sanofi/Regeneron
“Until then, Repatha or Praluent offer the most evidence-backed approach.”
Tirzepatide
“Simpson reports noticing its absence within 12 hours of his first tirzepatide injection”
Inclisiran
“Newer options — oral PCSK9 inhibitor Lerodalcibep, Inclisiran (siRNA mechanism), and Lerodalcibep (ambient-stable, no refrigeration required) — lower ApoB by 50–60% but currently lack equivalent outcomes trials.”
ezetimibe
“Meaningful cardiovascular risk reduction required adding rosuvastatin (Crestor) and ezetimibe”
Lerodalcibep
“Newer options — oral PCSK9 inhibitor Lerodalcibep, Inclisiran (siRNA mechanism), and Lerodalcibep (ambient-stable, no refrigeration required) — lower ApoB by 50–60% but currently lack equivalent outcomes trials.”
Crestor
by AstraZeneca
“Meaningful cardiovascular risk reduction required adding rosuvastatin (Crestor) and ezetimibe”
Zepbound
by Eli Lilly
“Bariatric surgeon Terry Simpson discusses his personal use of tirzepatide (Zepbound)”